These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 7918311)

  • 21. Association between apolipoprotein(a) phenotypes and coronary heart disease at a young age.
    Gazzaruso C; Garzaniti A; Buscaglia P; Bonetti G; Falcone C; Fratino P; Finardi G; Geroldi D
    J Am Coll Cardiol; 1999 Jan; 33(1):157-63. PubMed ID: 9935023
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lipoprotein (a) level, apolipoprotein (a) size, and risk of unexplained ischemic stroke in young and middle-aged adults.
    Beheshtian A; Shitole SG; Segal AZ; Leifer D; Tracy RP; Rader DJ; Devereux RB; Kizer JR
    Atherosclerosis; 2016 Oct; 253():47-53. PubMed ID: 27575936
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The low molecular weight apo(a) phenotype is an independent predictor for coronary artery disease in hemodialysis patients: a prospective follow-up.
    Kronenberg F; Neyer U; Lhotta K; Trenkwalder E; Auinger M; Pribasnig A; Meisl T; König P; Dieplinger H
    J Am Soc Nephrol; 1999 May; 10(5):1027-36. PubMed ID: 10232689
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetics and cardiovascular risk: a role for apolipoprotein(a) polymorphism.
    Gazzaruso C; Garzaniti A; Geroldi D; Finardi G
    Cardiologia; 1999 Apr; 44(4):347-54. PubMed ID: 10371786
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Elevated Lp(a) with a small apo(a) isoform in children: risk factor for the development of premature coronary artery disease.
    Dirisamer A; Widhalm H; Aldover-Macasaet E; Molzer S; Widhalm K
    Acta Paediatr; 2008 Dec; 97(12):1653-7. PubMed ID: 18684164
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Significance of apolipoprotein(a) phenotypes in acute coronary syndromes: relation with clinical presentation.
    Emanuele E; Peros E; Minoretti P; D'Angelo A; Montagna L; Falcone C; Geroldi D
    Clin Chim Acta; 2004 Dec; 350(1-2):159-65. PubMed ID: 15530473
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sequence polymorphisms in the apolipoprotein(a) gene and their association with lipoprotein(a) levels and myocardial infarction. The ECTIM Study.
    Brazier L; Tiret L; Luc G; Arveiler D; Ruidavets JB; Evans A; Chapman J; Cambien F; Thillet J
    Atherosclerosis; 1999 Jun; 144(2):323-33. PubMed ID: 10407493
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of lipoprotein(a) levels and apolipoprotein(a) phenotypes with coronary heart disease in patients with essential hypertension.
    Gazzaruso C; Buscaglia P; Garzaniti A; Falcone C; Mariotti S; Savino S; Bonetti G; Finardi G; Geroldi D
    J Hypertens; 1997 Mar; 15(3):227-35. PubMed ID: 9468449
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lipoprotein(a) and apolipoprotein(a) isoforms: no association with coronary artery calcification in the Dallas Heart Study.
    Guerra R; Yu Z; Marcovina S; Peshock R; Cohen JC; Hobbs HH
    Circulation; 2005 Mar; 111(12):1471-9. PubMed ID: 15781743
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relationship between apolipoprotein(a) size polymorphism and coronary heart disease in overweight subjects.
    Emanuele E; Peros E; Minoretti P; Falcone C; D'Angelo A; Montagna L; Geroldi D
    BMC Cardiovasc Disord; 2003 Dec; 3():12. PubMed ID: 14670093
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quantitation of plasma apolipoproteins in the primary and secondary prevention of coronary artery disease.
    Rader DJ; Hoeg JM; Brewer HB
    Ann Intern Med; 1994 Jun; 120(12):1012-25. PubMed ID: 8185133
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Apolipoprotein(a) phenotypes, Lp(a) concentration and plasma lipid levels in relation to coronary heart disease in a Chinese population: evidence for the role of the apo(a) gene in coronary heart disease.
    Sandholzer C; Boerwinkle E; Saha N; Tong MC; Utermann G
    J Clin Invest; 1992 Mar; 89(3):1040-6. PubMed ID: 1541665
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lipoprotein(a) and prevalent cardiovascular disease in a dialysis population: The Choices for Healthy Outcomes in Caring for ESRD (CHOICE) study.
    Longenecker JC; Coresh J; Marcovina SM; Powe NR; Levey AS; Giaculli F; Fink NE; Klag MJ
    Am J Kidney Dis; 2003 Jul; 42(1):108-16. PubMed ID: 12830462
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Assessment of asymptomatic coronary artery disease in apparently uncomplicated type 2 diabetic patients: a role for lipoprotein(a) and apolipoprotein(a) polymorphism.
    Gazzaruso C; Garzaniti A; Giordanetti S; Falcone C; De Amici E; Geroldi D; Fratino P
    Diabetes Care; 2002 Aug; 25(8):1418-24. PubMed ID: 12145244
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Apolipoprotein B, fibrinogen, HDL cholesterol, and apolipoprotein(a) phenotypes predict coronary artery disease in hemodialysis patients.
    Koch M; Kutkuhn B; Trenkwalder E; Bach D; Grabensee B; Dieplinger H; Kronenberg F
    J Am Soc Nephrol; 1997 Dec; 8(12):1889-98. PubMed ID: 9402091
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lipoprotein(a) levels and apolipoprotein(a) isoforms related to life style risk factors.
    Ishikawa S; Deguchi T; Hara K; Takuma S; Kayaba K; Tsutsumi A; Kario K; Igarashi M
    J Epidemiol; 1999 Feb; 9(1):32-9. PubMed ID: 10098351
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A prospective case-control study of lipoprotein(a) levels and apo(a) size and risk of coronary heart disease in Stanford Five-City Project participants.
    Wild SH; Fortmann SP; Marcovina SM
    Arterioscler Thromb Vasc Biol; 1997 Feb; 17(2):239-45. PubMed ID: 9081676
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of lipoprotein(a) levels and apolipoprotein(a) phenotypes with coronary artery disease in Type 2 diabetic patients and in non-diabetic subjects.
    Gazzaruso C; Garzaniti A; Falcone C; Geroldi D; Finardi G; Fratino P
    Diabet Med; 2001 Jul; 18(7):589-94. PubMed ID: 11553191
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Apo(a) isoforms do not predict risk for coronary heart disease in a Gulf Arab population.
    Akanji AO
    Ann Clin Biochem; 2000 May; 37 ( Pt 3)():360-6. PubMed ID: 10817252
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relationship between plasma lipoprotein (a), apolipoprotein (a) phenotypes, and other coronary heart disease risk factors in a Melbourne South Asian population.
    Xiong ZW; Wahlqvist ML; Ibiebele TI; Biegler BM; Balazs ND; Xiong DW; Lim YL
    Clin Biochem; 2004 Apr; 37(4):305-11. PubMed ID: 15003733
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.